FDA Proposes Rule on Products Made or Derived from Tobacco

Today, FDA announced in the Federal Register a proposed rule entitled “Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices, or Combination Products; Amendments to Regulations Regarding “Intended Uses.” This proposed rule describes the circumstances in which a product made or derived from tobacco that is intended for human consumption will be subject to regulation as a drug, device, or a combination product under the Federal Food, Drug, and Cosmetic Act (the FD&C Act). This action is intended to provide direction to regulated industry and to help avoid consumer confusion.

The proposed rule was developed in accordance with regulatory guidance and will be available for comment starting tomorrow, Friday, September 25, 2015, until Tuesday, November 24, 2015.

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

NIHB presents National Tribal Health Conference | Sheraton Grand at Wildhorse Pass in Chandler, Arizona | LEARN MORE AND REGISTER

75 Years Later:  The Impact of the 1950 Papers on Smoking and Lung Cancer | This symposium will celebrate the achievements that have occurred over the past 75 years in the fields of tobacco control, lung cancer epidemiology and causal inference.  Two seminal papers on lung cancer and smoking initiated these three areas of scholarship in 1950.  Since then, significant public health, policy, and research contributions have been made by scholars around the world.  In this symposium, speakers will highlight such accomplishments and present their current research in these fields. | DOWNLOAD FLIER | REGISTER HERE

Association of American Indian Physicians 53rd Annual Meeting | Hyatt Regency Seattle in Seattle, Washington | LEARN MORE AND REGISTER

National Lung Cancer Screening Day | Now in its fourth year, this initiative is kpowered by a dynamic collaboration among the American Cancer Society's National Lung Cancer Roundtable, GO2 for Lung Cancer, the Radiology Health Equity Coalition, and the American College of Radiology. | LEARN MORE